Neonatal abstinence syndrome: An update

Current Opinion in Pediatrics

Volumn 30, Issue 2, 2018, Pages 182-186

  Sanlorenzo, Lauren A ^a   Stark, Ann R ^a   Patrick, Stephen W ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

buprenorphine; maternal drug use; neonatal abstinence syndrome; nonpharmacologic treatment; withdrawal

Indexed keywords

BUPRENORPHINE; MORPHINE;

CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; DISEASE SEVERITY; DRUG EXPOSURE; GENETIC POLYMORPHISM; HEALTH CARE FACILITY; HUMAN; INCIDENCE; INFANT; INFANT CARE; NEONATAL ABSTINENCE SYNDROME; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; REVIEW; RURAL AREA; STANDARDIZATION; SUBURBAN AREA; TOTAL QUALITY MANAGEMENT; NEWBORN; RISK FACTOR; SEVERITY OF ILLNESS INDEX; UNITED STATES;

HUMANS; INFANT, NEWBORN; NEONATAL ABSTINENCE SYNDROME; QUALITY IMPROVEMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 85043319307     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0000000000000589     Document Type: Review

References (31)

1. Patrick SW, Davis MM, Lehman CU, Cooper WO. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol 2015; 35:667
2. Patrick SW, Schumacher RE, Benneyworth BD, et al. Neonatal abstinence syndrome and associated healthcare expenditures: United States, 2000-2009. JAMA 2012; 307:1934-1940
3. Finnegan LP, Connaughton JF Jr, Kron RE, Emich JP. Neonatal abstinence syndrome: assessment and management. Addict Dis 1975; 2:141-158
4. Jackson L, Ting A, McKay S, et al. A randomised controlled trial of morphine versus phenobarbitone for neonatal abstinence syndrome. Arch Dis Child Fetal Neonatal Ed 2004; 89:F300-F304
5. Hall ES, Wexelblatt SL, Crowley M, et al. A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome. Pediatrics 2014; 134:e527-e534
6. Hudak ML, Tan RC. Neonatal drug withdrawal. Pediatrics 2012; 129:e540-e560
7. Corr TE, Hollenbeak CS. The economic burden of neonatal abstinence syndrome in the United States. Addiction 2017; 112:1590-1599
8. Jumah NA. Rural, pregnant, and opioid dependent: a systematic review. Subst Abuse 2016; 10(Suppl 1):35-41
9. Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry 2014; 71:821-826
10. Ko JY, PatrickSW,Tong VT, et al. Incidence of neonatal abstinence syndrome-28 states, 1999-2013. MMWR Morb Mortal Wkly Rep 2016; 65:799-802
11. Villapiano NG, Winkelman TA, Kozhimannil KB, et al. Rural and urban differences in neonatal abstinence syndrome and maternal opioid use, 2004 to 2013. JAMA Pediatr 2017; 171:194-196
12. Miller AM, McDonald M, Warren MD. Neonatal abstinence syndrome surveillance annual report 2016. Nashville, TN: Tennessee Department of Health; 2017; Available from: https://www.tn.gov/assets/entities/health/attachments/ NAS-Annual-report-2016-FINAL.pdf. [Retrieved October 10, 2017]
13. Wachman EM, Hayes MJ, Sherva R, et al. Variations in opioid receptor genes in neonatal abstinence syndrome. Drug Alcohol Depend 2015; 155:253-259
14. Desai RJ, Huybrechts KF, Hernandez-Diaz S, et al. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study. BMJ 2015; 350:h2102
15. Huybrechts KF, Bateman BT, Desai RJ, et al. Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study. BMJ 2017; 358:j3326
16. American College of Obstetricians and Gynecologists Committee on Obstetric Practice. Committee opinion no. 637: marijuana use during pregnancy and lactation. Obstet Gynecol 2015; 126:234-238
17. O'Connor AB, Kelly BK, O'Brien LM. Maternal and infant outcomes following third trimester exposure to marijuana in opioid dependent pregnant women maintained on buprenorphine. Drug Alcohol Depend 2017; 180:200-203
18. Wachman EM, Hayes MJ, Brown MS, et al. Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome. JAMA 2013; 309:1821-1827
19. Mactier H, McLaughlin P, Gillis C, Osselton MD. Variations in infant CYP2B6 genotype associated with the need for pharmacological treatment for neonatal abstinence syndrome in infants of methadone-maintained opioid-dependent mothers. Am J Perinatol 2017; 34:918-921
20. Isemann BT, Stoeckle EC, Taleghani AA, Mueller EW. Early prediction tool to identify the need for pharmacotherapy in infants at risk of neonatal abstinence syndrome. Pharmacotherapy 2017; 37:840-848
21. Sarkar S, Donn SM. Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. J Perinatol 2006; 26:15-17
22. Patrick SW, Kaplan HC, Passarella M, et al. Variation in treatment of neonatal abstinence syndrome in US children's hospitals, 2004-2011. J Perinatol 2014; 34:867-872
23. Grossman MR, Berkwitt AK, Osborn RR, et al. An initiative to improve the quality of care of infants with neonatal abstinence syndrome. Pediatrics 2017; 139
24. Grossman MR, Osborn RR, Berkwitt AK. Neonatal abstinence syndrome: time for a reappraisal. Hosp Pediatr 2017; 7:115-116
25. Holmes AV, Atwood EC, Whalen B, et al. Rooming-in to treat neonatal abstinence syndrome: improved family-centered care at lower cost. Pediatrics 2016; 137
26. Newman A, Davies GA, Dow K, et al. Rooming-in care for infants of opioiddependent mothers: implementation and evaluation at a tertiary care hospital. Can Fam Physician 2015; 61:e555-e561
27. Mehta A, Forbes KD, Kuppala VS. Neonatal abstinence syndrome management from prenatal counseling to postdischarge follow-up care: results of a national survey. Hosp Pediatr 2013; 3:317-323
28. Howard MB, Schiff DM, Penwill N, et al. Impact of parental presence at infants' bedside on neonatal abstinence syndrome. Hosp Pediatr 2017; 7:63-69
29. Patrick SW, Schumacher RE, Horbar JD, et al. Improving care for neonatal abstinence syndrome. Pediatrics 2016; 137
30. Kraft WK, Adeniyi-Jones SC, Chervoneva I, et al. Buprenorphine for the treatment of the neonatal abstinence syndrome. N Engl J Med 2017; 376:2341-2348
31. Hall ES, Wexelblatt SL, Crowley M, et al. Implementation of a neonatal abstinence syndrome weaning protocol: a multicenter cohort study. Pediatrics 2015; 136:e803-e810